Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Gross Profit (2016 - 2025)

China Pharma Holdings filings provide 16 years of Gross Profit readings, the most recent being $150775.0 for Q4 2025.

  • On a quarterly basis, Gross Profit rose 193.89% to $150775.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$131950.0, a 93.35% increase, with the full-year FY2025 number at -$131950.0, up 93.35% from a year prior.
  • Gross Profit hit $150775.0 in Q4 2025 for China Pharma Holdings, up from -$59654.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $301936.0 in Q4 2021 to a low of -$1.0 million in Q2 2024.
  • Median Gross Profit over the past 5 years was -$136908.5 (2022), compared with a mean of -$127166.4.
  • Biggest five-year swings in Gross Profit: crashed 728.01% in 2021 and later surged 204.99% in 2023.
  • China Pharma Holdings' Gross Profit stood at $301936.0 in 2021, then tumbled by 85.86% to $42682.0 in 2022, then crashed by 285.46% to -$79158.0 in 2023, then plummeted by 102.87% to -$160589.0 in 2024, then skyrocketed by 193.89% to $150775.0 in 2025.
  • The last three reported values for Gross Profit were $150775.0 (Q4 2025), -$59654.0 (Q3 2025), and -$87010.0 (Q2 2025) per Business Quant data.